Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of HMR1964 vs Insulin Aspart in CSII for T1DM
NCT00046150Phase 3Completed
- Sponsor
- Sanofi
- Start
- May 2002
- Modality
- Peptides
- Countries
- 3
01
Overview
A Phase 3 trial of insulin glulisine in type 1 diabetes mellitus (T1D), sponsored by Sanofi. Started May 2002; status: completed.
02
Drugs
insulin glulisine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00046150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00046150.